Saturday, August 26, 2023 3:20:45 PM
From Brain Drain YrS AGO
& Incipient Nick Picking CHAOS .
The Static vs Multi Prong DYNAMICS needed where few EVER have demoed since 2014!!
UNLIKE the below evolution to FACTS as postED vs daily back & forthS:
1)From Civil to CRIMINAL! to RICO!!
2)Multiple APPROVALS vying for 1st whether MHRA or FDA:
ALL have a KEEN vested Political Interest
3)NWBO in Catbirds Seat due to June 2023 ASCO of Mechanisms of Action leading to MULTIPLE parties: $BLN PLUS
4)Giving the Market CREDENCE
VAULTING shares
5)Meeting UPLIST requirements which FEW are aware of HIGH HURDLES: either NASD or NYSEG
6) The New AMGEN in New Era
Personalized Immuno Oncology
7) NWBO for WEALTH GENERATION
99% iHub posters are focused: PEER/IMAGE/EGO pressure in CLASH of OLD Guard vs those few SWAT members
— maverick_1 (@maveric92283613) August 17, 2023
Rocking WATER LOGGED boat during SILENCE & INCAPABLE to AIRHEAD
Overboard in timid cooks!
FLOPPER posted: NOTHING (just face saving!)
Unchanged Carousel: CIRCUS of CLOWNS
#CANCER $NWBO
— maverick_1 (@maveric92283613) August 5, 2023
Catbird's seat :
June 2023 NWBO VIVID ASCO (biggest annual confab of the world's Oncology experts) of it's Mechanism of Action ETC https://t.co/gl9jMPlQ4v
Percolation of Big RX Oncology interests re
New ERA Personalized Immuno Onc
W/4 RA's Rolling Rvw
TIC TOCK
#DISRUPTOR #CANCER $NWBO
— maverick_1 (@maveric92283613) August 20, 2023
B4/Hallown/Thksg:
Compacted GUSHER
1) > $1 billion UPFRONT > 2 COLLABORATIONS beyond MRK, REGN: COMBO TRIALS with enviable royalty streams based on milestones
Early bird gets the worm
2)SHRS Zoom: MKT CREDENCE.. UPLIST
3)Up to 4 Apprvls
4)RICO! Instead
The UK's 2 + year delay in joining the world's largest collaborative research programme is bad news for anyone who wants to see better outcomes for UK cancer patients and that includes #braintumour patients - @braintumourrsch https://t.co/VAaOSzSlSG
— Hugh Adams (@hugh1eadams) August 25, 2023
These women when 20-30’s dedicated their lives 4 last 20-30 YEARS 2 extend & saving GBM lives as each of their parents died from it ie Beau Biden
— maverick_1 (@maveric92283613) August 16, 2023
2014:NWBO CEO We will be next AMGENhttps://t.co/EbUWf8VmFOhttps://t.co/LsaW2M44NAhttps://t.co/LsaW2M44NAhttps://t.co/FN92I4eopi
The ABOVE are just some of The HIGHLIGHTS in this EPIC to be in bookS & Movie Sequel
DIFFERENT STROKES for DIFFERENT FOLKS
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
